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Human hydrophobic surfactant polypeptide, W-B, purified from lung tissue by exclusion chromatography in organic solvents, has been character- 
ized. The polypcptide is79 residues long, has a C-terminal methionine, and contains even Cys residues. Native human SP-B lacks free thiol groups. 
Three intrachain disulfide bridges were defined. linking Cys” LO Cys”‘, Cys” to Cys” a nd CYS’~ to Cys*. The remaining Cys’” is concluded to link 
the protein chains into homodimers via an interchain disuifidc to its counterpart ina second SP-B polypcptide. These SS bridges are identical to 
those in the porcine form and confirm a consistant and unique disulfide pattern for SP-B polypeptides in general. 
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1. INTRODUCTION 
Pulmonary surfactant is synthesized and secreted by 
the alveolar type II cells as a complex of mainly 
phospholipids and proteins. It is a prerequisite for nor- 
mal respiration by lowering surface tension, thereby 
preventing alveolar collapse at end expiration [l]. Low 
levels of surfactant in premature babies are associated 
wit;4 respiratory distress [2], a common cause of neona- 
tal mortality [3]. This serious disease can now be effec- 
tively treated by exogenous instillation of surfactant 
preparations. Necessary components of such prepara- 
tions are phospholipids and two hydrophobic polypep- 
tides, SP-B and SP-C 141. 
SP-C from several species, including man, is a 33-35 
residue polypeptide [5,6] containing one or two (de- 
pendent on species) thioester-linked palmitoyl groups 
[7,8]. Porcine SP-B has been shown to contain 79 resi- 
dues in its longest form [9], to exist mainly as a 17.4 kDa 
homodimer and to lack covalently linked fatty acyl 
groups [7j, One interchain disulfiCe and three intrachain 
SS bridges have been determined for porcine SP-B [lo]. 
In contrast, for human SP-B only tentative and conflict- 
ing suggestions concerning the C-terminal end (see 
[11,12]) and the disulfide arrangement exist. Studies of 
human SP-I3 at the cDNA level, however, show that the 
airway polypeptide originates from a much larger 42 
kDa precursor [13-l 51. This study was undertaken in 
order to establish the disulfide bridge arrangement and 
Corrcpondencr &dress: J. Johansson, Departmenr of Chemistry I. 
Karolinska Institutet, S-104 01 Stockholm, Sweden. Fax: (46) 
8337462. 
Pubiished b)l Eiscvier Science Pl~biishers B. V. 
the location of the C-terminal end, and to confirm the 
overall structure of human SP-B by direct analysis of 
the airway form. 
2. MATERIALS AND METHODS 
2.1 I Prordt isolation 
The pulmonary phospholipid fraction was isolated [7,16] from 
human lung tissue obtGned after a tumor resection, SP-B was purified 
from the phospholipids by Sepbadex LH-60 chromatography in chlo- 
roform/methanol. 1:l (v/v), containing 5% 0.1 M HCI [16], 
2.2. Slruclural urraiysis 
For detection of free SH groups, native SP-B (25 nmol) was solubil- 
ized and denatured in 200 ~10.4 M Tris-HCU6 M guanidine-HCl/2 
mM EDTA/8 mM SDS, pH 8.1, and treated with4pmol [“C]iodoace- 
tare for 4 h at 37°C. 
For sequence analysis SP-B was reduced, [“Qarboxymethyiated 
[9] and degraded in an ABI 47OA gas-phase sequencer. Liberated 
phenylthiohydantoin (PTH) derivatives were analyzed by revsrs& 
phase high performance liquid chromatography (RP-HPLC) using a 
Hewlett-Packard 1090 instrument, or an ABI IZOA Analyzr. Under 
the conditions used diPTH-cystine eluted at the same Position as 
PTH-Tyr. Fragments of SP-B were generated by treatment of about 
100 yg [“C]carboxymethylated material with CNBr (0. I5 g/ml) in 70% 
formic acid for 24 h at room temperature. The peptides produced were 
separated in the two-phase system chlaroform/methanoUwater. 8:4:3 
(by vol). Hydrophilic peptides recovered inthe methonoVwatcr phase 
were further purified by RP-HPLC (Ultropac TSK ODS-120T. 4.6 x 
250 mm mlumn, flow I mUmin, linear gradient of acetonitrile in0.1% 
aqueous trilluoroacetic acid) and subjected to sequence analysis. The 
chloroform/methanol phase contained uncleaved SP-B. Amino acid 
compositions were determined with an LKB Alpha Plus or Beckman 
l21M analyzer after hydrolysis in 6 M HCVO.S% phenol for 24 h at 
I IOT. 
For assignment of disulfidc bridge;, native SP-9 wes c!eaved with 
pepsin (1:lO enzyme-to-substrate ratio, 24 h incubation at 37°C) in 5% 
formic acid [IO]. After evapomtion of the solvents and re-solubii- 
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ization in 30% acetic acid, the peptides produced were purified by 
RP-HPLC (conditions as above), 
3. RESULTS 
3.1. Amino acid sequence 
Human SP-B is deduced to be a 7Presidue polypep 
tide ending with a methionine (Fig. 1). The Gterminal 
Met was unambiguously observed in two peptides (C2 
and P9, Fig. I), that were produced independently, by 
C?JBr and pepsin treatment, respectively. The detection 
of a Met residue at the C-terminus of a CNBr peptide 
in itself strongly indicates that the methionine already 
detected was originally the C-terminal residue. The C- 
terminus established here is not in agreement with sug- 
gested structures of human SP-B with 78 residues [1 l] 
or SO-8 1 residues [ 121 but is supported by previous data 
from mass spectrometry [7]. 
All residues of the polypeptide, except at position 28, 
were unequivocally determined. At this position evi- 
dence for a possible Ile/Ala polymorphism was ob- 
tained. Analysis of the intact polypeptide clearly 
showed Ile2’, whereas analysis of a fragment starting at 
position 22 (C3, Fig. 1) identified Ala’“. The amino acid 
sequence deduced for human SP-I3 is in agreement with 
the amino acid composition obtained after hydrolysis 
for 24 h at 1 10°C, with expected low recoveries of the 
aliphatic branched-chain residues [5,9]. Total composi- 
tions of the fragments produced by CNBr or pepsin are 
also in agreement with the corresponding amino acid 
sequences. 
The structure of human SP-B with AlaZs now estab- 
lished by direct protein analysis is identical with the 
amino acid sequence of an internal part (positions 201- 
279) of human pro SP-B, confirming that the biologi- 
cally active airway polypeptide is a proteolytically de- 
rived cleavage product. No N-terminally truncated 
forms of human SP-8 were observed. This is in contrast 
to the situation with porcine SP-B, where a shorter form 
was found, lacking the first Wo residues of the full- 
length, 79-residue polypeptide 191. This species differ- 
ence might indicate that N-terminally truncated forms 
previously observed for SP-B and SP-C [5,6,8,9] are 
caused by secondary aminopeptidase-like activities 
rather than low specificity of the proteolytic enzyme(s) 
that liberate the active polypeptides. 
3.2. Disr@de bridge art-angetneni 
No carboxymethylcysteine could be detected by 
amino acid analysis after iodoacetate treatment of SP-B 
under denaturing but non-reducing conditions, This 
shows that in native SP-B all Cys residues are disulfide- 
linked, since other posttranslational modifications of 
the @ys residues are excluded as judged by the observed 
molecular mass of SP-B [7]. 
Cys-containing peptides isolated by RP-HPLC after 
cleavage of native SP-B with pepsin (Fig. 2) were identi- 
fied by amino acid analysis and further characterized by 
sequence analysis. Equimolar amounts of peptides cov- 
ering positions 70-74 and 10-12 (P2 and P7, Figs. 1 and 
2) eluted in one fraction; 30-37 and 45-47 (P3 and P4) 
in another; and l-l 3 and 70-79 (PlO and P9) in a third. 
Sequence analysis of the P2+P7 fraction released 
diPTH-cystine at cycle two, and analysis of the P3+P4 
fraction released it at cycle six. This establishes that 
peptides P2 and P7 are linked via a disulfide bridge, and 
that P3 and P4 are linked by another disulfide bridge. 
Sequence analysis of the PlO+P9 fraction was expected 
to release diPTH=cystine at two different positions (8 
and I I), but this derivative was not observed at any 
cycle. The failure to detect hese diPTH-cystine residues 
might be explained by low recoveries from shifts in the 
disulfide pattern after repeated coupling steps at alka- 
line pH. 
These results give the disulfide arrangement shown in 
Fig. 1, with intrachain disulfide bridges between Cyss- 
Cys”, Cys”-Cys” and Cy~~‘-Cys~~. No peptide con- 
taining Cys“” was identified. However, since all Cys res- 
r----II 
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-1 -P3- *P4- -P5- -c2- 
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Fig. I. Amino acid sequence and disulfide bridges of human surfactant ,polypeptide SP-9. Horizontrl lines below the sequence indicate residues 
identified by sequence analysis. Intact denotes analysis of uncleaved SP-B; PI-Pl4, analyses of fragments obtained by cleavage with pepsin; Cl-C3, 
analyses of those produced by cleavage with CNBr. At position 28, Ile and Ala were found upon analysis of intact material and C3, respectively. 
Lines connecting Cys residues represent the disulfidc bridges identified. CysU is indicated by a vertical line to be interchain-linked to another SP-B 
polypeptide. 
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Fig. 2. HPLC separation of pcptidc fragments of native human SP-B 
produced by pepsin cleavage. The positions of elution of peptides 
PI-P14 in Fig. 1 are indicated. 
idues are disulfide-linked (see above) the only possible 
linkage of this Cys is a Cys4s-(Y interchain disulflde 
bridge. 
4. DISCUSSION 
Human surfactant polypeptide, SP-B, like the porcine 
equivalent [9,10], is a 7%residue polypeptide with three 
intrachain disulfide bridges. The disulfides are now 
shown to be identically positioned in human and por- 
cine SP-B, i.e. linking the first half-cystine with the last, 
the second with the penultimate, and two centrally situ- 
ated half-cystines wirh each other (Fig. 1). Thus, disul- 
fide-mediated interactions between distant parts of the 
SP-B polypeptide appear structurally important, which 
is supported by a recent finding that reduction of SP-I3 
appears to result in a conformational change of the 
N-terminal segment [ 171. The functional significance of 
the close interaction between N- and C-terminal parts 
of SP-B is unclear since synthetic peptides correspond- 
ing to smaller parts of SP-B appear to exhibit some 
biological activity [18]. fiurthermore, it has been pro- 
posed that SP-B might be involved in binding functioris 
because of its excess of positive charges and an observed 
similarity between SP-B and the kringle domain [lo]. In 
conclusion, it is possible that intact SP-B contains mul- 
tiple binding sites for anionic phospholipids, and that 
the binding sites need not be linked in one polypeptide 
chain for the lowering of surface tension. 
Human SP-B is concluded to exist as a homodimer 
because of a Cy~~~-Cys~’ interchain SS bridge, compat- 
ible with the molecular mass. with the absence of a 
detectable free thiol group, and th.e fact that all other 
Cys residue5 are occupied in disu!fide bonding. The 
failure to detect a fragment containing Cys” might be 
explained by the hydrophobicity of the surrounding re- 
gion, rendering peptic cleavage or fragment isolation 
difficult. The only heterogeneity now detected for 
human SP-B is an apparent Be/Ala polymorphism at 
position 28. Therefore, the proposed coexistence of 
thiol-free dimeric and monomeric porcine SP-B due to 
a Cys/Leu polymorphism at position 57 [IO] does not 
seem to be a general phenomenon and the major form 
of native SP-B is concluded to be homodimeric. 
In summary, the identical disulfide patterns estab- 
lished for human and porcine SP-B by direct analyses 
of the polypeptides confirm a consistent and unique 
structure for this pulmonary surfactant molecule. 
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